Search Within

Fernando Lopez-Rios

Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Department of Pathology and Laboratory Medicine (9)
  2. GSK Faculty (9)
  3. Human Oncology and Pathogenesis Program (9)
  4. Surgery (9)
  5. Tow Center for Developmental Oncology (TCDO) (9)
People
  1. Marc Ladanyi (9)
  2. Valerie Rusch (9)
  3. Adam Olshen (6)
  4. Maureen Zakowski (6)
  5. Peter Illei (4)
  6. Sanaa Hussain (4)

More People

Years
  1. 2007 (2)
  2. 2006 (1)
  3. 2005 (3)
  4. 2004 (1)
  5. 2003 (2)
Publications
  1. Laboratory Investigation (3)
  2. Modern Pathology (3)
  3. Cancer Research (1)
  4. Lancet (1)
  5. Lung Cancer (1)
Publishers
  1. Nature Publishing Group (3)
  2. Nature Research (3)
  3. American Association for Cancer Research (1)
  4. Elsevier Ireland Ltd. (1)
  5. Elsevier Science, Inc. (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MET in pleural mesothelioma: Mutational screening, phosphorylation status, and sensitivity to MET inhibition
    Meeting Abstract

    Shimizu, S.; Lopez-Rios, F.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • MET in pleural mesothelioma: Mutational screening, phosphorylation status, and sensitivity to MET inhibition
    Meeting Abstract

    Shimizu, S.; Lopez-Rios, F.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Global gene expression profiling of pleural mesotheliomas: Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction
    Journal Article

    Lopez-Rios, F.; Chuai, S.; Flores, R.; Shimizu, S.; Ohno, T.; Wakahara, K.; Illei, P. B.; Hussain, S.; Krug, L.; Zakowski, M. F.; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Global gene expression profiling of epithelioid mesotheliomas and lung adenocarcinomas for the identification of new differential diagnostic markers and the development of a microarray-based prediction model
    Meeting Abstract

    Lopez-Rios, F.; Szoke, J.; Hussain, S.; Chuai, S.; Olshen, A. B.; Rusch, V.; Zakowski, M. F.; Gerald, W. L.; Ladanyi, M.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Global gene expression profiling of epithelioid mesotheliomas and lung adenocarcinomas for the identification of new differential diagnostic markers and the development of a microarray-based prediction model
    Meeting Abstract

    Lopez-Rios, F.; Szoke, J.; Hussain, S.; Chuai, S.; Olshen, A. B.; Rusch, V.; Zakowski, M. F.; Gerald, W. L.; Ladanyi, M.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • Gene expression profiling of malignant mesothelioma for prognostic prediction and identification of potential therapeutic targets and differential diagnostic markers
    Meeting Abstract

    Lopez-Rios, F.; Chuai, S.; Hussain, S.; Szoke, J.; Gerald, W.; Zakowski, M.; Olshen, A.; Flores, R.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids
    Journal Article

    Lopez-Rios, F.; Illei, P. B.; Rusch, V.; Ladanyi, M.
    Lancet (2004)

    Fulltext@MSK | Save
  • SV40 infection and p16/CDKN2A deletion as alternative mechanisms of p53 and RB pathway co-inactivation in a series of 65 mesotheliomas
    Meeting Abstract

    Lopez-Rios, F.; Illei, P. B.; Zhao, Z.; Rusch, V.; Zakowski, M. F.; Ladanyi, M.
    Modern Pathology (2003)

    Fulltext@MSK | Save
  • SV40 infection and p16/CDKN2A deletion as alternative mechanisms of p53 and RB pathway co-inactivation in a series of 65 mesotheliomas
    Meeting Abstract

    Lopez-Rios, F.; Illei, P. B.; Zhao, Z.; Rusch, V.; Zakowski, M. F.; Ladanyi, M.
    Laboratory Investigation (2003)

    Fulltext@MSK | Save